177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Clinical trial NCT04529044 · RECRUITING

Trial details

NCT number: NCT04529044
Sponsor: OHSU Knight Cancer Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Recurrent Breast Carcinoma

Start date: 2026-06-30
Primary completion: 2027-12-20
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.